|
|
|
|
 |
Press Releases
All Releases
 |
Pain Therapeutics Invited to Present At Two Investor Conferences
Jun 4, 2009
|
7.5 KB |
|
| |
SAN MATEO, Calif., June 4, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at the Goldman Sachs Healthcare Conference on Tuesday, June 9th at 3:45 p.m. Eastern Time. Pain Therapeutics' management will also present at the Needham Life Sciences Conference on Thursday, June 11th at 1:30 p.m. ...
|
|
Pain Therapeutics Initiates Clinical Study in Cancer Patients
May 5, 2009
|
10.5 KB |
|
| |
SAN MATEO, Calif., May 5, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), announced the initiation of another clinical study for PTI-188, an investigational drug intended to treat a lethal form of skin cancer called metastatic melanoma (MM). This study follows the release of promising data in an earlier Phase I study for PTI-188, pu...
|
|
Pain Therapeutics Announces First Quarter 2009 Financial Results
Apr 30, 2009
|
15.8 KB |
|
| |
SAN MATEO, Calif., Apr 30, 2009 (GlobeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today reported financial results for the quarter ended March 31, 2009. Net loss for the quarter ended March 31, 2009 was $1.8 million, or $0.04 per diluted share, compared to net income of $2.6 million, or $...
|
|
Pain Therapeutics to Present At the Barclays Capital Healthcare Conference
Mar 6, 2009
|
8.5 KB |
|
| |
SAN MATEO, Calif., Mar 6, 2009 (GlobeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that Remi Barbier, the Company's chairman, president and chief executive officer, will present at the Barclays Capital Global Healthcare Conference in Miami Beach, Florida on Wednesday, March 11th at 2:30 p.m. Eastern Time...
|
|
Pain Therapeutics Announces Year-End 2008 Financial Results, Outlines 2009 Business Priorities
Feb 5, 2009
|
17.7 KB |
|
| |
Feb 5, 2009 (GlobeNewswire via COMTEX News Network) --
Net income of $0.35 Per Share for 2008
$190 Million of Cash on Hand, No Debt
Cash Requirements in 2009 Expected to be Under $10 Million
SAN MATEO, Calif., Feb. 5, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical c...
|
|
Pain Therapeutics Receives Complete Response Letter From FDA for REMOXY(R)
Dec 11, 2008
|
10.8 KB |
|
| |
SAN MATEO, Calif., Dec 11, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Pain Therapeutics, Inc. (Nasdaq: PTIE) has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for REMOXY(R), an abuse-resistant controlled-release form of oxycodone. Based on its review, the FDA has...
|
|
Pain Therapeutics to Present At the Piper Jaffray Health Care Conference
Nov 25, 2008
|
10.1 KB |
|
| |
SAN MATEO, Calif., Nov 25, 2008 (GlobeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that Remi Barbier, the Company's chairman, president and chief executive officer, will participate in the 20th Annual Piper Jaffray Health Care Conference in New York on Wednesday, December 3rd at 10:00 a.m. Eastern Time....
|
|
Pain Therapeutics to Present At Two Upcoming Investor Conferences
Nov 10, 2008
|
8.9 KB |
|
| |
SAN MATEO, Calif., Nov 10, 2008 (GlobeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management is scheduled to present at the following investor conferences:
* The 17th Annual Credit Suisse Health Care Conference in Phoenix, Arizona
Thursday, November 13th at 4:00 p.m. Mountain Time
...
|
|
Pain Therapeutics Announces Third Quarter 2008 Financial Results
Oct 29, 2008
|
17.0 KB |
|
| |
SAN MATEO, Calif., Oct 29, 2008 (GlobeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the three and nine months ended September 30, 2008. Net income for the quarter ended September 30, 2008 was $15.2 million, or $0.35 per diluted share, compared to $3.2 million, or $0.07 per diluted sh...
|
|
Pain Therapeutics to Present At the UBS Life Sciences Conference
Sep 16, 2008
|
8.7 KB |
|
| |
SAN MATEO, Calif., Sep 16, 2008 (GlobeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at the UBS Global Life Sciences Conference on Tuesday, September 23rd at 4:00 p.m. Eastern Time in New York.
A live audio webcast of the presentation will be open to all on our web site, w...
|
|
$20,000,000.00 Received by Pain Therapeutics
Sep 2, 2008
|
11.3 KB |
|
| |
SAN MATEO, Calif., Sep 2, 2008 (GlobeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced it has received $20,000,000 in milestone payments from King Pharmaceuticals, Inc. (NYSE:KG), its exclusive commercial partner for REMOXY(r) and other abuse-resistant prescription pain medications.
Receipt of $15,000,00...
|
|
Pain Therapeutics and King Pharmaceuticals Develop a New Abuse-Resistant Prescription Pain Medication
Aug 27, 2008
|
12.0 KB |
|
| |
SAN MATEO, Calif. and BRISTOL, Tenn., Aug 27, 2008 (GlobeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) and King Pharmaceuticals, Inc. (NYSE:KG) today announced they are developing a new abuse-resistant prescription pain medication called PTI-721. Like REMOXY(r) (controlled-release oxycodone), PTI-721's patented formulat...
|
|
Pain Therapeutics and King Pharmaceuticals Announce Final Data of REMOXY Phase III Study at World Pain Congress in Scotland
Aug 19, 2008
|
15.7 KB |
|
| |
GLASGOW, Scotland, Aug 19, 2008 (BUSINESS WIRE) -- Pain Therapeutics, Inc. (NASDAQ: PTIE) and King Pharmaceuticals, Inc. (NYSE: KG) today presented the final data set of a previously announced pivotal Phase III study of REMOXY(R), an investigational drug to treat chronic pain. The final data confirm REMOXY provides effective around-the-clock analge...
|
|
FDA Accepts REMOXY New Drug Application and Grants Priority Review
Aug 12, 2008
|
12.8 KB |
|
| |
SAN MATEO, Calif. and BRISTOL, Tenn., Aug 12, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) and King Pharmaceuticals, Inc. (NYSE:KG) today announced that the New Drug Application (NDA) for REMOXY(r) was accepted and granted Priority Review by the U.S. Food and Drug Administration (FDA). The FDA typically gran...
|
|
Pain Therapeutics Announces Second Quarter 2008 Financial Results
Jul 30, 2008
|
16.0 KB |
|
| |
SAN MATEO, Calif., Jul 30, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the three and six months ended June 30, 2008. Net loss for the quarter ended June 30, 2008 was $1.0 million, or $0.02 per diluted share, compared to net income of $3.4 million, or $0.07 per diluted sh...
|
|
Pain Therapeutics Encouraged by Results of Melanoma Clinical Study
Jun 16, 2008
|
11.6 KB |
|
| |
SAN MATEO, Calif., Jun 16, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today the successful completion of its first clinical study utilizing a novel melanoma treatment. This treatment consisted of dosing patients with a monoclonal antibody labeled with a radio-isotope. The Company owns exclusive w...
|
|
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Jun 10, 2008
|
13.6 KB |
|
| |
SAN MATEO, Calif. and BRISTOL, Tenn., Jun 10, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) and King Pharmaceuticals, Inc. (NYSE:KG) today announced that a New Drug Application (NDA) for Remoxy(tm) has been submitted to the U.S. Food and Drug Administration (FDA). Remoxy, a unique long-acting formulation of o...
|
|
Pain Therapeutics to Present At Two Upcoming Investor Conferences
Jun 3, 2008
|
8.8 KB |
|
| |
SAN MATEO, Calif., Jun 3, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management is scheduled to present at the following investor conferences:
* Goldman Sachs Global Healthcare Conference in Laguna Niguel,
California
Tuesday, June 10th at 3:20 p.m. Pacific Tim...
|
|
Pain Therapeutics Announces First Quarter 2008 Financial Results
May 7, 2008
|
15.7 KB |
|
| |
SAN MATEO, Calif., May 7, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today reported financial results for the three months ended March 31, 2008. Net income for the quarter ended March 31, 2008 was $2.6 million, or $0.06 per share, compared to net income of $12.6 million, or $0...
|
|
Pain Therapeutics Increases Stock Buyback Plan to $30,000,000
Mar 31, 2008
|
10.6 KB |
|
| |
SAN MATEO, Calif., Mar 31, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today it has increased the size of its stock buyback plan to $30.0 million, effective immediately through March 2009. This represents a 50% increase from the Company's previously announced buyback plan. The Company has purchase...
|
|
|
= add release to Briefcase
|
   |
|
|
|
|
|
